IART 241115 7.50C (IART241115C7500) Stock Options, News & Quotes

Account Info

Log Out

US OptionsDetailed Quotes

IART241115C7500

Watchlist

0.00
0.000.00%

15min DelayClose Nov 5 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Raises Target Price to $26
Moomoo News15:31 ET · Ratings
Integra LifeSciences Price Target Raised to $26 From $21 at Truist
TipRanks14:40 ET
Integra LifeSciences Is Maintained at Sell by Citigroup
Dow JonesNov 5 10:07 ET · Ratings
Integra Lifesciences Analyst Ratings
BenzingaNov 5 09:56 ET · Ratings
Morgan Stanley Remains a Sell on Integra Lifesciences (IART)
TipRanksNov 5 09:07 ET · Ratings
Express News | Integra Lifesciences Holdings Corp : Citigroup Raises Target Price to $22 From $16
ReutersNov 5 06:28 ET

Comments

Money Mover

Jul 1 10:35

Going to miss guidance/earnings

$Integra Lifesciences (IART.US)$ its a buy at $24

Money Mover

Jun 27 14:20

$Integra Lifesciences (IART.US)$ Integra LifeSciences Price Target Cut to $25.00/Share From $45.00 by Wells Fargo

Moomoo AI

Feb 11 08:35

EPS growth doesn't align with share price, indicating it may not reflect business performance or growth expectations may have been high. Integra LifeSciences Holdings' performance led to a 3% annual loss for shareholders over five years. Investors should note 3 warning signs.

While Shareholders of Integra LifeSciences Holdings (NASDAQ:IART) Are in the Red Over the Last Three Years, Underlying Earnings Have Actually Grown

Moomoo AI

Jan 29 04:30

Insider transactions suggest a positive outlook for Integra LifeSciences Holdings, with insiders net buying the stock. The level of insider ownership indicates a reasonable degree of alignment with shareholder interests.

Several Insiders Invested In Integra LifeSciences Holdings Flagging Positive News

Moomoo AI

Jan 15 05:36

Integra LifeSciences Holdings trades at a low price, suggesting a buying opportunity. Higher cash flow is expected, potentially boosting share valuation. The positive outlook seems not fully factored into the share price, indicating it's not too late to buy IART.

At US$42.94, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?